Ascentage Pharma Group International (AAPG) Long-Term Investments (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Long-Term Investments for 3 consecutive years, with $563970.4 the latest figure, recorded in Q4 2025.

• Quarterly Long-Term Investments rose 255.04% year-over-year to $563970.4 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $563970.4 (up 255.04% YoY) and the FY2025 annual result came in at $572000.0, up 266.67% from the prior year.
• Long-Term Investments declined to $563970.4 in Q4 2025 per AAPG's latest filing, from $645000.0 in the prior quarter.
• Over the last five years, Long-Term Investments for AAPG reached as high as $2.4 million in Q4 2023 and fell as low as $158845.1 in Q4 2024.
• A 3-year average of $932155.9 and a median of $604485.2 in 2025 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2024 — Long-Term Investments tumbled 93.27% — and 2025, when it soared 255.04%.
• Year by year, Long-Term Investments stood at $2.4 million in 2023, then slumped by 93.27% to $158845.1 in 2024, then surged by 255.04% to $563970.4 in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $563970.4, $645000.0, and $158845.1 for Q4 2025, Q2 2025, and Q4 2024 respectively.